High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma

BACKGROUND: Glioblastoma (GBM) is a highly malignant tumor with poor prognosis, and new treatment strategies are urgently needed. Currently, the role of triggering receptor expressed on myeloid cells 1 (TREM-1) in tumors has been studied, but the role of TREM-1 in GBM remains unclear. METHODS: Immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ke, Guo, Qianqian, Zhang, Xianwei, Li, Yanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238274/
https://www.ncbi.nlm.nih.gov/pubmed/37274309
http://dx.doi.org/10.2147/OTT.S407892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238274/
https://www.ncbi.nlm.nih.gov/pubmed/37274309
http://dx.doi.org/10.2147/OTT.S407892

Ejemplares similares